Psoriasis

Poster 35

Long-term safety and efficacy of roflumilast cream 0.3% in adult patients with chronic plaque psoriasis: results from a 52-week...

12 views

Psoriasis

Poster 36

Roflumilast cream, a once-daily, potent phosphodiesterase-4 inhibitor, in chronic plaque psoriasis patients: Efficacy and safety...

12 views

Psoriasis

Poster 37

Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients With Moderate to Severe Plaque Psoriasis Who Had Inadequate...

14 views

Psoriasis

Poster 38

Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, Versus Placebo in Scalp, Nail, and Palmoplantar Psoriasis...

11 views

Psoriasis

Poster 39

Deucravacitinib Long-term Efficacy and Safety in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO Program

10 views

Psoriasis

Poster 40

Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Efficacy by Baseline Disease Characteristics and Demographics in Two Pivotal Phase 3...

8 views

Psoriasis

Poster 41

Efficacy and Safety of Calcipotriene Topical Foam 0.005% in Maintenance Treatment of Moderate Plaque-Type Psoriasis After Combination...

8 views

Psoriasis

Poster 42

Patient Preference for Calcipotriene/Betamethasone Fixed Combination Cream vs Foam: A Pilot Study

7 views

Psoriasis

Poster 43

Effectiveness, safety, and quality of life from a Phase 4 real-world study of tildrakizumab in patients with moderate-to-severe psoriasis

9 views

Psoriasis

Poster 44

Maintenance of bimekizumab efficacy through 2 years in patients with moderate to severe plaque psoriasis: Pooled results from five...

12 views

Psoriasis

Poster 45

Bimekizumab infection rates in patients with moderate to severe plaque psoriasis: Analysis of pooled data from 2 years of treatment...

20 views

Psoriasis

Poster 46

Bimekizumab versus secukinumab continuous maintenance of response at every visit through one year in patients...

7 views

Psoriasis

Poster 47

Bimekizumab speed of response in patients with moderate to severe plaque psoriasis: Results from four phase 3/3b trials...

10 views

Psoriasis

Poster 48

Bimekizumab in patients with moderate to severe plaque psoriasis by bodyweight: Pooled results from phase 3 trials

5 views

Psoriasis

Poster 49

Bimekizumab early treatment response translates into cumulative benefits in health-related quality of life in patients...

8 views

DERM2022 POSTERS

We invite you to view the DERM2022 Posters. The posters are categorized by disease state.
Click on the disease state below to view all posters in that category.

Search by
Poster
Number

Search by Poster Number

Search by
Poster
Number